Group 1: Nuclear Fusion - The National Ignition Facility (NIF) achieved a new record of 8.6 megajoules of nuclear fusion energy, more than doubling the previous milestone of 3.15 megajoules set in 2022 [1] - This breakthrough is seen as a significant step towards making nuclear fusion a practical and sustainable energy solution, with NIF successfully achieving net energy gain for the eighth time [1] Group 2: Measurement and Testing in Manufacturing - The Ministry of Industry and Information Technology issued a policy document aimed at advancing measurement innovation in China's manufacturing sector, focusing on key technologies and the integration of military and civilian applications [2] - The manufacturing measurement market in China is projected to exceed 150 billion yuan by 2025, with a compound annual growth rate of over 10% [2] Group 3: Oil Prices and Geopolitical Tensions - Following Israel's attack on Iranian nuclear facilities, global oil prices surged, with Brent crude rising by 8.39% to $75.18 per barrel [3] - Concerns over potential disruptions in oil transport through the Strait of Hormuz, a critical passage for one-fifth of the world's oil supply, have led to warnings from investment banks that prices could spike to $120-130 per barrel if significant interruptions occur [3] Group 4: AI in Pharmaceutical Development - A strategic research collaboration was established between CSPC Pharmaceutical Group and AstraZeneca, focusing on AI-driven drug discovery, with CSPC receiving an upfront payment of $110 million and potential milestone payments exceeding $5 billion [4] - This partnership highlights the growing recognition of Chinese pharmaceutical companies' capabilities in AI drug discovery, shifting the process from traditional methods to AI design [4] Group 5: Low-altitude Economy - The 2025 Digital Low-altitude Conference will be held in Suzhou, focusing on key developments in low-altitude economy sectors such as drones and flight services [5] - Suzhou is emerging as a hub for low-altitude economic development, with numerous companies involved across the entire industry chain [5] Group 6: Brain-Computer Interface Technology - China has initiated its first prospective clinical trial for invasive brain-computer interface technology, marking it as the second country globally to enter this phase [6] - The advancement in this technology is expected to improve the quality of life for patients with spinal cord injuries and amputations [6]

2025.06. 15 本文字数：2329，阅读时长大约4分钟 作者 | 第一财经 钱童心 中国的侵入式脑机接口设备正加速进入临床。 近日，多家官方媒体披露，中国科学院脑科学与智能技术卓越创新中心（赵郑拓研究组及李雪研究 组）联合复旦大学附属华山医院（吴劲松/路俊锋团队），与相关企业合作，成功开展了中国首例侵 入式脑机接口的前瞻性临床试验。 据介绍，这不仅是国内第一次达到医疗器械注册临床试验规范要求的脑机接口研究，更意味着我国在 侵入式脑机接口技术上成为继美国之后，全球第二个进入临床试验阶段的国家。 第一财经记者搜索公开信息发现，这一消息已于上个月被"上海科技"公众号报道，涉及企业为上海阶 梯医疗科技。此外，来自北京、杭州的脑机接口公司也都在开发相关设备，并计划进入临床。 面向运动功能障碍患者的脑机接口 5月8日，阶梯医疗创始人、中国科学院脑智卓越中心研究员赵郑拓与李雪首次向媒体披露了受试者 术后首月的脑控训练成果。受试者在接受侵入式脑机接口系统植入后，仅用2-3周的训练，便实现了 下象棋、玩赛车游戏等功能，达到了与普通人控制电脑触摸板相近的水平。 赵郑拓表示，脑机接口主要分为两种模式：一是"从大脑向外输出信 ...

摘要 / 以伊冲突对A股有何影响？ 送走了关税，没想到又迎来了以伊战火这个黑天鹅，周五A股毫无疑问又为中东 买单了。 | 图2、伊以冲突爆发后(6月13日)全球大类资产涨跌幅 | | --- | | 股市指数&股指期货 | 1 11 1 | UNIVAL / LITT | | | --- | --- | --- | --- | | | | 大英资产 | | | 全球重要指数 | 涨跌幅,% | 债券市场 | 变动幅度,bp | | 俄罗斯MOEX | 0.6 | 美国国债收益率-2年期 | 6.0 | | 英国富时100 | -0.4 | 美国国债收益率-10年期 | 5.0 | | 巴西IBOVESPA | -0.4 | 外汇 | 涨跌幅,% | | 恒生指数 | -0.6 | 美元指数 | 0.3 | | 印度Senssex30 | -0.7 | 欧元兑美元 | -0.3 | | 上证指数 | -0.8 | 高岸人民币兑美元 | 0.1 | | 韩国综合指数 | -0.9 | 日元兑美元 | -0.4 | | 日 经225 | -0.9 | 大宗商品 | 涨跌幅, % | | 法国CAC40 | -1.0 ...

脑机接口主要分为两种模式：一是"从大脑向外输出信息"，如解码运动意图控制外部设备；二是"向大 脑输入信息"，如人工视觉、听觉重建。 复旦大学附属华山医院院长毛颖教授在本月初召开的第20届亚洲神经肿瘤年会上透露，由上海华山医院 和北京宣武医院牵头的脑机接口临床队列研究已启动患者入组工作，旨在进一步验证侵入式脑机接口治 疗方案的有效性、安全性等关键问题。 中国的侵入式脑机接口设备正加速进入临床。 近日，多家官方媒体披露，中国科学院脑科学与智能技术卓越创新中心（赵郑拓研究组及李雪研究组） 联合复旦大学附属华山医院（吴劲松/路俊锋团队），与相关企业合作，成功开展了中国首例侵入式脑 机接口的前瞻性临床试验。 据介绍，这不仅是国内第一次达到医疗器械注册临床试验规范要求的脑机接口研究，更意味着我国在侵 入式脑机接口技术上成为继美国之后，全球第二个进入临床试验阶段的国家。 第一财经记者搜索公开信息发现，这一消息已于上个月被"上海科技"公众号报道，涉及企业为上海阶梯 医疗科技。此外，来自北京、杭州的脑机接口公司也都在开发相关设备，并计划进入临床。 面向运动功能障碍患者的脑机接口 5月8日，阶梯医疗创始人、中国科学院脑智卓越中心 ...

Core Viewpoint - The article highlights the debut of Tesla Bot at the 2025 Hangzhou International Humanoid Robot and Robotics Technology Expo, showcasing advancements in humanoid robotics and the participation of over 200 leading companies in the industry [1][3][5]. Group 1: Event Overview - The expo will take place from June 20 to June 22, 2025, at the Hangzhou Grand Convention and Exhibition Center, featuring a combination of forums, exhibitions, and interactive experiences [1]. - The event is organized by the Zhejiang Robot Industry Development Association and aims to present cutting-edge humanoid robot technologies and future living scenarios [1]. Group 2: Key Exhibitors and Technologies - Notable exhibitors include Alibaba Cloud, Hangzhou Six Little Dragons, and various other leading companies, showcasing technologies such as embodied intelligence, multimodal interaction, and brain-computer interfaces [5]. - The expo will cover the entire industry chain, including complete robots, key components, and application scenarios [5]. Group 3: Forums and Networking Opportunities - The event will host several forums, including the Hangzhou Humanoid Robot Conference focusing on industry trends and policy analysis, and a connection conference aimed at fostering business cooperation and technology commercialization [9][10]. - A dedicated forum for investment and technology innovation in the humanoid robotics sector will also take place, providing opportunities to explore new investment avenues [10]. Group 4: Interactive Experiences - The expo will feature interactive activities, including a talent show and educational events aimed at engaging families and promoting technology awareness [11][13]. - Attendees will have the chance to win limited gifts through participation in interactive sessions [11].

一水 发自 凹非寺 量子位 | 公众号 QbitAI 用意念操控万物的"脑机接口"，就这样离我们更近了？！ 据央妈最新报道， 我国已成功开展首例侵入式脑机接口临床试验 —— 一位因意外事故导致四肢截肢的男子，现在 仅凭意念 就能玩五子棋游戏、发短信等等。 这项研究由中国科学院脑科学与智能技术卓越创新中心，联合复旦大学附属华山医院以及相关企业合作完成。 其成功标志着，除了马斯克的Neuralink，我国成为 全球第二个 进入侵入式脑机接口技术临床试验阶段的国家。 而且所植入的神经电极目前全球尺寸最小、柔性最强—— 植入体仅硬币大小 （为Neuralink产品1/2） ，超柔性电极约为头发丝的1/100 （超过Neuralink百倍） 。 对于这一新进展，网友们除了纷纷感叹科幻照进现实，更有脑洞大开的同学表示： 以后能直接把课本植入进去了 （不想学可以直说~doge） 幻想归幻想，但目前已经能确定下一步研究方向—— 短期会尝试让受试者使用机械臂，使他可以在物理生活中完成抓握、拿杯子等操作。 长期还可能涉及对复杂物理外设进行控制，例如对机器狗、具身智能机器人等智能设备的控制，拓展生活边界。 而以上这些目标的实现，均 ...

一水 发自 凹非寺 量子位 | 公众号 QbitAI 用意念操控万物的"脑机接口"，就这样离我们更近了？！ 据央妈最新报道， 我国已成功开展首例侵入式脑机接口临床试验 —— 一位因意外事故导致四肢截肢的男子，现在 仅凭意念 就能玩五子棋游戏、发短信等等。 这项研究由中国科学院脑科学与智能技术卓越创新中心，联合复旦大学附属华山医院以及相关企业合作完成。 其成功标志着，除了马斯克的Neuralink，我国成为 全球第二个 进入侵入式脑机接口技术临床试验阶段的国家。 而且所植入的神经电极目前全球尺寸最小、柔性最强—— 植入体仅硬币大小 （为Neuralink产品1/2） ，超柔性电极约为头发丝的1/100 （超过Neuralink百倍） 。 长期还可能涉及对复杂物理外设进行控制，例如对机器狗、具身智能机器人等智能设备的控制，拓展生活边界。 而以上这些目标的实现，均离不开团队在脑机接口 软硬件方面所取得的突破 —— 用上了半导体加工工艺 作为一种侵入式脑机接口 （需要通过微创手术将电极植入大脑） ，团队在硬件设计上核心追求一个目标： 最大程度降低对脑组织的损伤 。 对于这一新进展，网友们除了纷纷感叹科幻照进现实，更有 ...

1.老凤祥证券部工作人员：与字节合作的AI眼镜目前尚未取得销售许可证，预计9月后上市 据蓝鲸新闻，就有关老凤祥将与字节合作推出AI眼镜事宜，记者致电老凤祥证券部，相关工作人员回应 称，老凤祥确实会在"老博会"推出AI眼镜，但目前该产品尚未取得销售许可证，正处于检测、测试及完善 阶段，预计9月后上市销售。至于具体与字节的合作，该工作人员称，目前双方仅签署了业务合作协 议，"这款AI眼镜镜框由老凤祥负责提供，其余部件通过采购集成，可与老凤祥眼镜APP连接，后台接入豆 包大模型。" 2.哪吒汽车正式进入破产重整程序 6月13日，全国企业破产重整案件信息网显示，哪吒汽车关联公司合众新能源汽车股份有限公司破产审查案 件更新信息，新增管理人机构浙江子城律师事务所，管理人主要负责人等信息。 点评：销量冠军陨落，重整求生待新生。 3.美国总统特朗普于本周五正式批准日本制铁公司以149亿美元收购美国钢铁公司的交易。 特朗普签署了一项行政命令，表示若双方与美国财政部签署协议，解决交易中存在的国家安全问题，则该 收购可以推进。随后，两家公司宣布已签署相关协议，满足了行政命令的要求，意味着该交易已获得正式 批准。据介绍，该协议包括到 ...

Core Insights - The first invasive brain-computer interface (BCI) clinical trial in China is transforming the life of its subject, allowing him to control games using his thoughts, achieving efficiency comparable to that of a typical user with a touchpad [1] - China has become the second country globally, after the United States, to conduct invasive BCI clinical trials, with several metrics surpassing those of Neuralink, founded by Elon Musk [1][2] - The research is a collaboration between the Shanghai Institute of Neuroscience and Fudan University Huashan Hospital, contributing to Shanghai's goal of becoming a global technology innovation hub [1] Technology Comparison - The Shanghai BCI technology features ultra-thin and flexible electrodes, measuring only 1/5 to 1/7 the size of those used by Neuralink, significantly reducing damage to brain tissue [2] - The implanted device is the smallest globally, with a diameter of 26mm and a thickness of less than 6mm, which is half the size of Neuralink's product [2] Surgical Procedure - The surgical procedure for the invasive BCI is less invasive than Neuralink's, requiring only a small groove in the skull rather than penetrating it, making it more patient-friendly [3] Research and Development - The BCI research is led by young scientists who have returned to China, highlighting the importance of domestic talent in advancing this technology [4][5] - The Shanghai Institute has established a micro-nano electronic processing platform, enabling precise fabrication of BCI devices and accelerating research progress [6] Future Developments - The next version of the BCI system, expected by the end of this year or early next year, will feature 256 information transmission channels, four times the current capacity, and a smaller size [7] - Future applications aim to enhance motor control for paralyzed patients and potentially restore speech for those with language impairments [7] Industry Vision - The BCI technology is seen as a foundational technology for human enhancement and human-machine integration, with aspirations for consumer-level applications in the future [8] - Shanghai's "Future Industry Cultivation Action Plan" aims to establish a global innovation hub for BCI products by 2030, reflecting a clear vision for the industry's growth [8]

Core Viewpoint - The article highlights the successful initiation of China's first invasive brain-computer interface (BCI) clinical trial, marking a significant advancement in the field and positioning China as the second country globally to enter this phase after the United States [1]. Group 1: Clinical Trial and Patient Outcomes - The clinical trial involves a male subject who lost all four limbs due to an electric shock accident. Since the implantation of the BCI device in March 2025, the system has operated stably without infections or electrode failures for over a month. The subject achieved functionalities such as playing chess and racing games within 2-3 weeks of training, demonstrating control comparable to that of a typical user with a computer touchpad [1]. - The BCI system is expected to significantly improve the quality of life for patients with complete spinal cord injuries, double upper limb amputations, and amyotrophic lateral sclerosis once it receives approval for registration and market launch [1]. Group 2: Technological Advancements - The BCI system developed by the research teams is noted for having the smallest and most flexible neural electrodes globally, with a cross-sectional area only 1/5 to 1/7 that of Neuralink's electrodes. This design minimizes damage to brain tissue and enhances compatibility with neural interfaces [2]. - The system is the only one in China to have received a registration-type inspection report and can stably collect single-neuron spike signals, providing a solid data foundation for applications [3]. Group 3: Surgical and Operational Efficiency - The implanted device has a diameter of 26mm and a thickness of less than 6mm, making it the smallest brain-controlled implant globally, only half the size of Neuralink's product. This allows for a less invasive surgical procedure, reducing risks and recovery time [3]. - The design of the BCI system is based on principles of neuroscience, allowing for similar control levels to Neuralink with fewer implanted electrodes, thus minimizing patient risk [4]. Group 4: Future Applications - Following successful trials in non-human primates, the project team aims to enable the subject to control a robotic arm for physical tasks such as grasping and holding objects. Future developments may include controlling complex physical devices like robotic dogs and intelligent agents, thereby expanding the subject's capabilities in daily life [4].